SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 5.53 |
Enterprise Value ($M) | 1.74 |
Book Value ($M) | 3.05 |
Book Value / Share | 1.00 |
Price / Book | 1.81 |
NCAV ($M) | 2.37 |
NCAV / Share | 0.77 |
Price / NCAV | 2.33 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.61 |
Return on Assets (ROA) | -0.63 |
Return on Equity (ROE) | -1.57 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.89 |
Current Ratio | 1.89 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 5.22 |
Assets | 5.91 |
Liabilities | 2.86 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.15 |
Operating Income | -18.79 |
Net Income | -18.83 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -21.34 |
Cash from Investing | -0.44 |
Cash from Financing | 21.01 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Markey John | 6.50 | -14.20 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
6,241 | 29,042 | 21.49 | |
5,526 | 1,762 | 313.62 | |
2,742 | 7,552 | 36.31 | |
5,220 | 29,230 | 17.86 | |
19,475 | 41,649 | 46.76 | |
(click for more detail) |
Similar Companies | |
---|---|
SNOA – Sonoma Pharmaceuticals, Inc. | SNPX – Synaptogenix, Inc. |
SNTI – Senti Biosciences, Inc. | SPRC – SciSparc Ltd. |
SRZN – Surrozen, Inc. |
Financial data and stock pages provided by
Fintel.io